PRESS
      PR PharmaResearch Holds the International Academic Rejuran Symposium in Thailand
      2023. 09. 06

      PharmaResearch Holds the International Academic Rejuran Symposium in Thailand

      It expands the global presence of Rejuran by sharing its in-house patented technology known as DOT™ PN





      PharmaResearch, represented by co-CEOs Thinkyou Kim and Kang Ki-Seock, announced that it successfully held the International Academic Rejuran Symposium, which took place at The Athenee Hotel  in Thailand on August 24, 2023. 


      At this symposium, which was attended by 550 medical professionals from Thailand, 13 prominent medical experts from Japan, Singapore, and Ukraine participated as speakers. They shared insights into PharmaResearch’s unique patented technologies known as DOT™ PDRN/PN, highlighting the excellence of these technologies and recent relevant advances. 


      Particularly, the Ukraine speaker, who presented cases of using Rejuran for refugees, drew significant attention from numerous medical professionals.


      A PharmaResearch official stated, “The performance and safety of PharmaResearch’s DOT® technology have been verified based on ample clinical data accumulated over the past 10 years. We will constantly share the distinctive technological prowess, efficacy, and safety of Rejuran.” 


      PharmaResearch’s flagship brand Rejuran® is a medical device designed to temporarily improve facial wrinkles by combining polynucleotides (PNs), regenerative substances extracted from salmon, with this company’s patented technology DNA Optimizing Technology (DOT™). Rejuran® has been supplied based on regulatory approval in approximately 20 countries, including China, Japan, Singapore, Ukraine, and Thailand.